Recent studies indicate that stem cell transplants may offer a breakthrough treatment for Parkinson's disease. Two independent research teams demonstrated that transplanted stem cells produced dopamine in patients, alleviating severe symptoms. With about 1 million Parkinson's sufferers in the U.S., this research is significant; the FDA has approved one of these treatments for phase 3 trials. This advance offers hope to halt the disease's progression, as these stem cells can develop into dopamine-producing neurons, critical for treating the debilitating effects of Parkinson's.
The idea is to place these neuron progenitors right where you need them to connect with other neurons in the brain, says Dr. Viviane Tabar.
Now we have the potential to really, really halt this disease in its tracks, says Dr. Mya Scheiss.
Positive early results indicate that stem cells transplanted into Parkinson's patients may ease symptoms and produce dopamine.
The FDA has cleared a stem cell treatment for a phase 3 study, marking a significant step towards approval.
Collection
[
|
...
]